Imunon, Inc. Investment Income, Nonoperating
Imunon, Inc. (IMNN) reported Investment Income, Nonoperating of $2.41 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2021-05-14
- Imunon, Inc. investment income, nonoperating for the quarter ending 2021-03-31 was $2.41K, a 97.27% decline year-over-year.
- Imunon, Inc. investment income, nonoperating for the quarter ending 2020-12-31 was $524.00, a 99.23% decline year-over-year.
- Imunon, Inc. investment income, nonoperating for the quarter ending 2020-09-30 was $10.11K, a 94.20% decline year-over-year.
- Imunon, Inc. investment income, nonoperating for the quarter ending 2020-06-30 was $20.96K, a 85.51% decline year-over-year.
- Imunon, Inc. investment income, nonoperating for fiscal 2020 was $119.91K, a 76.06% decline from fiscal 2019.
- Imunon, Inc. investment income, nonoperating for fiscal 2019 was $500.88K, a 41.62% increase from fiscal 2018.
- Imunon, Inc. investment income, nonoperating for fiscal 2018 was $353.68K, a 1258.17% increase from fiscal 2017.
- Imunon, Inc. investment income, nonoperating for fiscal 2017 was $26.04K, a 3.27% decline from fiscal 2016.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 3 month as first filed | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 9 month | Investment Income, Nonoperating 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | $2.41K 10-Q · filed 2021-05-14 | $2.94K derived: sum of 2 quarters · filed 2021-05-14 | $13.05K derived: sum of 3 quarters · filed 2021-05-14 | $34.01K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2020-12-31 | $524.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $10.64K derived: sum of 2 quarters · filed 2021-03-19 | $31.60K derived: sum of 3 quarters · filed 2021-03-19 | $119.91K 10-K · filed 2021-03-19 | |
| 2020-09-30 | $10.11K 10-Q · filed 2020-11-16 | $31.07K derived: sum of 2 quarters · filed 2020-11-16 | $119.38K 10-Q · filed 2020-11-16 | $187.43K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2020-06-30 | $20.96K 10-Q · filed 2020-08-14 | $109.27K 10-Q · filed 2020-08-14 | $177.32K derived: sum of 3 quarters · filed 2021-05-14 | $351.76K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2020-03-31 | $88.31K 10-Q · filed 2021-05-14 | $156.36K derived: sum of 2 quarters · filed 2021-05-14 | $330.80K derived: sum of 3 quarters · filed 2021-05-14 | $475.40K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $68.05K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $242.49K derived: sum of 2 quarters · filed 2021-03-19 | $387.09K derived: sum of 3 quarters · filed 2021-03-19 | $500.88K 10-K · filed 2021-03-19 | |
| 2019-09-30 | $174.44K 10-Q · filed 2020-11-16 | $319.04K derived: sum of 2 quarters · filed 2020-11-16 | $432.83K 10-Q · filed 2020-11-16 | $532.76K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | $144.60K 10-Q · filed 2020-08-14 | $258.39K 10-Q · filed 2020-08-14 | $358.32K derived: sum of 3 quarters · filed 2020-08-14 | $464.89K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $113.79K 10-Q · filed 2020-05-15 | $213.72K derived: sum of 2 quarters · filed 2020-05-15 | $320.29K derived: sum of 3 quarters · filed 2020-05-15 | $393.75K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $99.93K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $206.50K derived: sum of 2 quarters · filed 2020-03-25 | $279.96K derived: sum of 3 quarters · filed 2020-03-25 | $353.68K 10-K · filed 2020-03-25 | |
| 2018-09-30 | $106.56K 10-Q · filed 2019-11-14 | $180.03K derived: sum of 2 quarters · filed 2019-11-14 | $253.75K 10-Q · filed 2019-11-14 | $275.85K derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $73.46K 10-Q · filed 2019-08-14 | $147.19K 10-Q · filed 2019-08-14 | $169.28K derived: sum of 3 quarters · filed 2019-08-14 | $169.81K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $73.72K 10-Q · filed 2019-05-15 | $95.82K derived: sum of 2 quarters · filed 2019-05-15 | $96.35K derived: sum of 3 quarters · filed 2019-05-15 | $96.87K derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $22.10K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $22.62K derived: sum of 2 quarters · filed 2019-03-29 | $23.15K derived: sum of 3 quarters · filed 2019-03-29 | $26.04K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $524.00 10-Q · filed 2017-11-14 | $1.05K derived: sum of 2 quarters · filed 2018-11-14 | $3.94K 10-Q · filed 2018-11-14 | $8.13K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $524.00 10-Q · filed 2018-11-14 | $1.43K 10-Q · filed 2017-08-14 | $3.42K 10-Q · filed 2018-08-14 | $7.61K derived: sum of 3 quarters · filed 2018-11-14 | $15.74K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-03-31 | $1.99K 10-Q · filed 2018-05-11 | $7.08K derived: sum of 2 quarters · filed 2018-05-11 | $15.21K derived: sum of 3 quarters · filed 2018-05-11 | $19.57K derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | $5.09K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | $13.22K derived: sum of 2 quarters · filed 2018-03-27 | $17.58K derived: sum of 3 quarters · filed 2018-03-27 | $26.92K 10-K · filed 2018-03-27 | |
| 2016-09-30 | $8.13K 10-Q · filed 2017-11-14 | $12.49K derived: sum of 2 quarters · filed 2017-11-14 | $21.83K 10-Q · filed 2017-11-14 | $36.67K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | $4.36K 10-Q · filed 2017-08-14 | $13.70K 10-Q · filed 2017-08-14 | $28.54K derived: sum of 3 quarters · filed 2017-08-14 | $44.04K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $9.34K 10-Q · filed 2017-05-12 | $24.18K derived: sum of 2 quarters · filed 2017-05-12 | $39.68K derived: sum of 3 quarters · filed 2017-05-12 | $56.55K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | $14.84K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $30.34K derived: sum of 2 quarters · filed 2017-03-24 | $47.21K derived: sum of 3 quarters · filed 2017-03-24 | $63.59K 10-K · filed 2017-03-24 | |
| 2015-09-30 | $15.50K 10-Q · filed 2016-11-10 | $32.37K derived: sum of 2 quarters · filed 2016-11-10 | $48.74K 10-Q · filed 2016-11-10 | $99.42K derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | $16.86K 10-Q · filed 2016-08-15 | $33.24K 10-Q · filed 2016-08-15 | $83.92K derived: sum of 3 quarters · filed 2016-08-15 | $110.44K derived: sum of 4 quarters · filed 2016-08-15 | |
| 2015-03-31 | $16.38K 10-Q · filed 2016-05-16 | $67.06K derived: sum of 2 quarters · filed 2016-05-16 | $93.57K derived: sum of 3 quarters · filed 2016-05-16 | $117.31K derived: sum of 4 quarters · filed 2016-05-16 | |
| 2014-12-31 | $50.68K derived: 10-K 6 month − 10-Q 3 month · filed 2015-03-12 | $77.19K 10-K · filed 2015-03-12 | $100.93K derived: sum of 3 quarters · filed 2015-11-05 | $77.19K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $26.52K 10-Q · filed 2015-11-05 | $50.25K derived: sum of 2 quarters · filed 2015-11-05 | $57.27K 10-Q · filed 2015-11-05 | -$100.01K derived: sum of 4 quarters · filed 2015-11-05 | |
| 2014-06-30 | $23.73K 10-Q · filed 2015-08-10 | $30.75K 10-Q · filed 2015-08-10 | -$126.52K derived: sum of 3 quarters · filed 2015-08-10 | $18.01K derived: sum of 4 quarters · filed 2015-08-10 | |
| 2014-03-31 | $7.02K 10-Q · filed 2015-05-11 | -$150.26K derived: sum of 2 quarters · filed 2015-05-11 | -$5.72K derived: sum of 3 quarters · filed 2015-05-11 | ||
| 2013-12-31 | -$157.28K derived: 10-K 6 month − 10-Q 3 month · filed 2015-03-12 | -$12.74K 10-K · filed 2015-03-12 | -$12.74K 10-K · filed 2016-03-30 | ||
| 2013-09-30 | $144.53K 10-Q · filed 2014-11-10 | $228.23K 10-Q · filed 2014-11-10 | |||
| 2012-12-31 | $52.32K 10-K · filed 2015-03-12 | ||||
| 2011-12-31 | $174.06K 10-K · filed 2013-03-18 | ||||
| 2010-12-31 | $32.29K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |